Maja Mandić

619 total citations
21 papers, 484 citations indexed

About

Maja Mandić is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Maja Mandić has authored 21 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 8 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Maja Mandić's work include Immunotherapy and Immune Responses (8 papers), T-cell and B-cell Immunology (6 papers) and vaccines and immunoinformatics approaches (5 papers). Maja Mandić is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), T-cell and B-cell Immunology (6 papers) and vaccines and immunoinformatics approaches (5 papers). Maja Mandić collaborates with scholars based in United States, Serbia and Slovakia. Maja Mandić's co-authors include John M. Kirkwood, Hassane M. Zarour, Walter J. Storkus, Anna Lokshin, Xiao‐Jun Huang, Tatiana Raskovalova, Elieser Gorelik, Yunyun Su, Edwin K. Jackson and Stergios Moschos and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Maja Mandić

19 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maja Mandić United States 12 247 246 195 66 34 21 484
Vibeke Sundvold Norway 7 247 1.0× 286 1.2× 111 0.6× 49 0.7× 22 0.6× 10 519
Catherine Phillips United States 13 210 0.9× 280 1.1× 104 0.5× 34 0.5× 12 0.4× 34 506
Shigemi Sasawatari Japan 11 205 0.8× 177 0.7× 92 0.5× 22 0.3× 70 2.1× 16 442
Mark Biffen United Kingdom 13 229 0.9× 299 1.2× 62 0.3× 29 0.4× 27 0.8× 24 525
Jan Lee United States 12 222 0.9× 740 3.0× 202 1.0× 15 0.2× 25 0.7× 19 903
Xiaodong Zhu China 8 183 0.7× 200 0.8× 137 0.7× 9 0.1× 62 1.8× 19 461
Sandra Rollins United States 9 339 1.4× 184 0.7× 193 1.0× 11 0.2× 23 0.7× 10 534
Anselm Sommer Germany 10 209 0.8× 74 0.3× 97 0.5× 14 0.2× 29 0.9× 10 377
Akie Maehara Japan 11 164 0.7× 278 1.1× 70 0.4× 21 0.3× 28 0.8× 18 492
Laìa Masvidal Sweden 11 340 1.4× 152 0.6× 89 0.5× 11 0.2× 33 1.0× 17 552

Countries citing papers authored by Maja Mandić

Since Specialization
Citations

This map shows the geographic impact of Maja Mandić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maja Mandić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maja Mandić more than expected).

Fields of papers citing papers by Maja Mandić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maja Mandić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maja Mandić. The network helps show where Maja Mandić may publish in the future.

Co-authorship network of co-authors of Maja Mandić

This figure shows the co-authorship network connecting the top 25 collaborators of Maja Mandić. A scholar is included among the top collaborators of Maja Mandić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maja Mandić. Maja Mandić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mandić, Maja & Edward D. Yeboah. (2025). Primary Closure in Animal Bites to Hands: A 7-year Retrospective Cohort Study. SHILAP Revista de lepidopterología. 6(1). 49–52.
2.
Mandić, Maja, et al.. (2024). Childhood-to-adulthood body size trajectory and cancer risk: a prospective cohort study. European Journal of Public Health. 34(Supplement_3).
3.
Donnenberg, Vera S., Philip Chaikin, Maja Mandić, et al.. (2019). Core Entrustable Professional Activities in Clinical Pharmacology for Entering Residency: Common Problem Drugs and How to Prescribe Them. The Journal of Clinical Pharmacology. 59(7). 915–922. 1 indexed citations
4.
Ilić, Tamara, et al.. (2017). Cardiopulmonary metastrongyloidosis of dogs and cats contribution to diagnose. Veterinarski glasnik. 71(2). 69–86. 6 indexed citations
5.
Donnenberg, Vera S., Maja Mandić, John C. Rhee, et al.. (2017). Core Entrustable Professional Activities in Clinical Pharmacology for Entering Residency: Biologics. The Journal of Clinical Pharmacology. 57(8). 947–955. 3 indexed citations
6.
Burris, James F., Michael A. Tortorici, Maja Mandić, Michael Neely, & Michael D. Reed. (2016). Dosage Adjustments Related to Young or Old Age and Organ Impairment. The Journal of Clinical Pharmacology. 56(12). 1461–1473. 11 indexed citations
7.
Ilić, Tamara, et al.. (2015). Dog and cat respiratory capilariasis - clinical, parasitological and epidemiological significance. SHILAP Revista de lepidopterología. 69(5-6). 417–428. 6 indexed citations
8.
Mandić, Maja, Luka Drinovec, Sanja Glišić, et al.. (2014). Demonstration of a Direct Interaction between β2-Adrenergic Receptor and Insulin Receptor by BRET and Bioinformatics. PLoS ONE. 9(11). e112664–e112664. 18 indexed citations
9.
Wesa, Amy, Maja Mandić, Jennifer L. Taylor, et al.. (2014). Circulating Type-1 Anti-Tumor CD4+T Cells are Preferentially Pro-Apoptotic in Cancer Patients. Frontiers in Oncology. 4. 266–266. 17 indexed citations
10.
Moschos, Stergios J., Cindy Sander, Wenjun Wang, et al.. (2010). Pharmacodynamic (Phase 0) Study Using Etaracizumab in Advanced Melanoma. Journal of Immunotherapy. 33(3). 316–325. 20 indexed citations
11.
12.
Moschos, Stergios, Maja Mandić, John M. Kirkwood, Walter J. Storkus, & Michael T. Lotze. (2008). Focus on FOCIS: Interleukin 2 treatment associated autoimmunity. Clinical Immunology. 127(2). 123–129. 11 indexed citations
13.
Gigante, Margherita, Maja Mandić, Amy Wesa, et al.. (2008). Interferon-alpha (IFN-α)–conditioned DC Preferentially Stimulate Type-1 and Limit Treg-type In Vitro T-cell Responses From RCC Patients. Journal of Immunotherapy. 31(3). 254–262. 40 indexed citations
14.
Wesa, Amy, Maja Mandić, Jennifer Taylor, et al.. (2008). Enhancement in Specific CD8+ T Cell Recognition of EphA2+ Tumors In Vitro and In Vivo after Treatment with Ligand Agonists. The Journal of Immunology. 181(11). 7721–7727. 24 indexed citations
15.
Raskovalova, Tatiana, Anna Lokshin, Xiao‐Jun Huang, et al.. (2007). Inhibition of Cytokine Production and Cytotoxic Activity of Human Antimelanoma Specific CD8+ and CD4+ T Lymphocytes by Adenosine-Protein Kinase A Type I Signaling. Cancer Research. 67(12). 5949–5956. 101 indexed citations
16.
Moschos, Stergios, Amanda Smith, Maja Mandić, et al.. (2007). SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomas. Oncogene. 26(29). 4216–4225. 71 indexed citations
17.
Vujanović, Lazar, Maja Mandić, Walter C. Olson, John M. Kirkwood, & Walter J. Storkus. (2007). A Mycoplasma Peptide Elicits Heteroclitic CD4+ T Cell Responses against Tumor Antigen MAGE-A6. Clinical Cancer Research. 13(22). 6796–6806. 32 indexed citations
18.
Mandić, Maja, Florence Castelli, Bratislav Janjic, et al.. (2005). One NY-ESO-1-Derived Epitope That Promiscuously Binds to Multiple HLA-DR and HLA-DP4 Molecules and Stimulates Autologous CD4+ T Cells from Patients with NY-ESO-1-Expressing Melanoma. The Journal of Immunology. 174(3). 1751–1759. 57 indexed citations
19.
Zarour, Hassane M., Maja Mandić, Pavol Kudela, et al.. (2005). Randomized Phase I-II Study of Vaccination With CpG 7909, Montanide ISA 720 and NY-ESO-1 Peptides for Patients With Stage III/IV Melanoma and NY-ESO-1+ Tumors: An Interim Analysis. Journal of Immunotherapy. 28(6). 661–662. 1 indexed citations
20.
Mandić, Maja, Christine Almunia, Daniel Gillet, et al.. (2003). The alternative open reading frame of LAGE-1 gives rise to multiple promiscuous HLA-DR-restricted epitopes recognized by T-helper 1-type tumor-reactive CD4+ T cells.. PubMed. 63(19). 6506–15. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vibeke Sundvold Breakdown of academic impact, for papers by Catherine Phillips Breakdown of academic impact, for papers by Shigemi Sasawatari Breakdown of academic impact, for papers by Mark Biffen Breakdown of academic impact, for papers by Jan Lee Breakdown of academic impact, for papers by Xiaodong Zhu Breakdown of academic impact, for papers by Sandra Rollins Breakdown of academic impact, for papers by Anselm Sommer Breakdown of academic impact, for papers by Akie Maehara Breakdown of academic impact, for papers by Laìa Masvidal
Rankless by CCL
2026